Navigation Links
Gene Activity May Affect Acute Myeloid Leukemia Outcome
Date:12/21/2010

TUESDAY, Dec. 21 (HealthDay News) -- For acute myeloid leukemia patients, overactive genes in their leukemic stem cells (LSC) can translate into a more difficult struggle to overcome their disease and achieve prolonged remission, new research reveals.

"In many cancers, specific subpopulations of cells appear to be uniquely capable of initiating and maintaining tumors," the study authors explained in their report. The researchers identified 52 LSC genes that, when highly active, appear to prompt worse outcomes among acute myeloid leukemia (AML) patients.

The finding is reported in the Dec. 22/29 issue of the Journal of the American Medical Association.

Between 2005 and 2007, study author Andrew J. Gentles, of Stanford University in Palo Alto, Calif., and colleagues examined gene activity in a group of AML patients as well as healthy individuals. Separate data concerning AML tumors in four groups of patients (totaling more than 1,000) was also analyzed.

In one of the patient groups, the investigators found that higher activity levels among 52 LSC genes meant a 78 percent risk of death within a three-year period. This compared with a 57 percent risk of death in the same time frame for AML patients with lower gene activity among these specific "signature" genes.

In another AML patient group, the research team observed that higher gene activity prompted an 81 percent risk for experiencing a disease set-back over three years, compared with just a 48 percent risk among patients with low gene activity.

What's more, Gentles and his colleagues found that higher activity among these 52 LSC genes generally meant a poorer response to chemotherapy treatment and lower remission rates.

The authors suggested that by "scoring" the activity levels of these 52 genes from low to high, clinicians might be able to better predict how well AML patients will respond to therapy. The finding could also help advance the design of future studies that aim to improve treatment strategies overall.

"Ultimately, this model has major implications for cancer therapy, most notably that in order to achieve cure, the cancer stem cells must be eliminated," the study authors said in a journal news release.

In the opinion of Dr. Nelson Chao, a professor of medicine and immunology, as well as chief of the division of cellular therapy at Duke University in Durham, N.C., the current work represents an effort to craft a highly personalized approach to disease treatment.

"This is the holy grail of personalized medicine, which is to find an individual signature with a disease so that each patient is handled as an individual. Because not everyone who has AML has the same tumor," Chao explained.

"And there are two implications with this," Chao added. "One is the prediction part. If we can predict how a particular patient may fare with treatment we can, for example, decide that someone at very high risk may need more aggressive or more investigational type of approaches."

And, he noted, "The flip side of that is that if we can learn what specific pathways are activated in a patient's leukemic stem cells, then we could end up turning to drugs that might be quite different from what we normally think of using today for AML. It may mean we end up using different drugs that we aren't even thinking of at this point. But of course, we have to look at this as a long-term goal."

More information

For more on myeloid leukemia treatment, visit the U.S. National Cancer Institute.

-- Alan Mozes

SOURCES: JAMA/Archives, news release, Dec. 21, 2010; Nelson Chao, M.D., professor, medicine and immunology, and chief, cellular therapy division, Duke University, Durham, N.C.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Being a good sport can be critical to maintaining lifelong physical activity
2. PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans
3. Activity Level Seems to Decline Throughout College Years
4. For Many Teens, Oral Sex Leads to Riskier Activity
5. PTSD Linked to Hyperactivity in Right Brain
6. Gene activity in the brain depends on genetic background
7. Resting brain activity associated with spontaneous fibromyalgia pain
8. Children have a negative impact on physical activity among individuals with heart disease
9. Concordia researcher leads study that finds kids reduce physical activity for heart patients
10. Inactivity no contributor to childhood obesity epidemic
11. Teenage physical activity reduces risk of cognitive impairment in later life
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Activity May Affect Acute Myeloid Leukemia Outcome
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX ... media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes ... use drop zones. Editors can select from a variety of flip book animations. In ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare ... enhances the WellnessPro platform by expanding the treatment modalities available in a ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
(Date:12/6/2016)... With opioids commonly used for pain management for workplace ... that has led to nationwide fatalities. The synthetic opioid ... than heroin or morphine, resulting in likelihood of addiction, abuse or ... , , ... operations, Behavioral Health for HMC HealthWorks, explained the opioid drug is ...
(Date:12/6/2016)... , Dec. 6, 2016  Blueprint Medicines Corporation ... and developing targeted kinase medicines for patients with genomically ... underwritten public offering of $125,000,000 million in shares of ... grant the underwriters a 30-day option to purchase up ... its common stock in connection with the public offering. ...
Breaking Medicine Technology: